First Time Loading...

CI Medical Co Ltd
TSE:3540

Watchlist Manager
CI Medical Co Ltd Logo
CI Medical Co Ltd
TSE:3540
Watchlist
Price: 3 930 JPY -1.13% Market Closed
Updated: Apr 26, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
CI Medical Co Ltd

Wall Street analysts forecast CI Medical Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CI Medical Co Ltd is 4 800 JPY .

Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
4 800 JPY
22% Upside
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
4 800 JPY
22% Upside
Highest
Price Target
Not Available
CI Medical Co Ltd Competitors:
Price Targets
W
Wayfair Inc
38% Upside
1833
Ping An Healthcare and Technology Co Ltd
77% Upside
FLWS
1-800-Flowers.Com Inc
35% Upside
3031
Raccoon Holdings Inc
45% Upside
W
Wayfair Inc
38% Upside
1833
Ping An Healthcare and Technology Co Ltd
77% Upside
FLWS
1-800-Flowers.Com Inc
35% Upside
3031
Raccoon Holdings Inc
45% Upside
HEPS
D Market Elektronik Hizmetler ve Ticaret AS
83% Upside
ROO
Deliveroo PLC
20% Upside
TPW
Temple & Webster Group Ltd
3% Upside
PDD
Pinduoduo Inc
45% Upside

Revenue
Forecast

Revenue Estimate
CI Medical Co Ltd

For the last 8 years the compound annual growth rate for CI Medical Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 12%.

12%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
CI Medical Co Ltd

Operating Income forecast
is not available for
CI Medical Co Ltd

Net Income
Forecast

Net Income Estimate
CI Medical Co Ltd

For the last 8 years the compound annual growth rate for CI Medical Co Ltd's net income is 8%. The projected CAGR for the next 3 years is 20%.

8%
Past Growth
20%
Estimated Growth
Estimates Accuracy
-9%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CI Medical Co Ltd's stock price target?
Price Target
4 800 JPY

According to Wall Street analysts, the average 1-year price target for CI Medical Co Ltd is 4 800 JPY .

What is CI Medical Co Ltd's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for CI Medical Co Ltd's revenue is 12%. The projected CAGR for the next 3 years is 12%.

What is CI Medical Co Ltd's Net Income forecast?
Projected CAGR
20%

For the last 8 years the compound annual growth rate for CI Medical Co Ltd's net income is 8%. The projected CAGR for the next 3 years is 20%.

ALPHA SPREAD
Join more than 131,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.